This study identifies TRIM36 as a novel E3 ligase that targets DDX3X for proteasomal degradation, thereby driving macrophage M2 polarization and ameliorating TFI. The TRIM36/DDX3X axis may provide a promising therapeutic target for TFI treatment.
Shao et al. (Mon,) studied this question.